Clinical trial Recruiting at 1 site Interventional Ages 50 to 74

Digital intervention for obesity and depression in older racial and ethnic adults

Official title: Digital InteGrated Behavioral treatmeNt for Comorbid obesITy and deprEssion Among Racial and Ethnic Adults Age 50 and Older (IGNITE)

Run by University of Illinois Chicago · NCT06636058 · Data updated 2026-11-12

This study is testing a digital program that helps older adults from racial and ethnic backgrounds manage their weight and depression with the support of a virtual coach and other tools.

More Obesity trials

Quick facts

Study typeInterventional
Ages50 Years to 74 Years
SexAll
Enrollment440 (estimated)
SponsorUniversity of Illinois Chicago
Academic / other
Locations2 sites (Chicago, Illinois and 1 other locations)
StatusRecruiting
StartedJanuary 21, 2025
Main results expectedApril 14, 2028
Study endsOctober 13, 2028
Registry record updatedAugust 18, 2026
Trial IDNCT06636058 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 50-74 with a BMI between 27.0 and 44.9, experiencing moderate to moderately severe depressive symptoms, and who self-identify as racial or ethnic minorities.

Probably not a fit

Patients with pre-existing diabetes, coronary heart disease, or other serious health conditions, as well as those unable to access the internet, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial tests a fully digital intervention called vCare, which combines a virtual coach for depression management with a video-based program for weight loss. Participants aged 50 and older, who self-identify as racial or ethnic minorities and have comorbid obesity and depression, will be randomly assigned to receive either immediate or delayed access to the intervention. The study aims to evaluate the efficacy of vCare in improving weight and depression symptoms over a 12-month period, while also identifying predictors of treatment success and characterizing participant experiences. Participants will receive a study iPad, a wireless weight scale, and a wearable activity tracker to facilitate their engagement in the program.

Why it matters

Potential benefit: If successful, this intervention could significantly improve weight management and reduce depressive symptoms in older adults from racial and ethnic minority backgrounds.

How similar studies have gone: Other studies have shown promise in using digital interventions for obesity and depression, but this specific integrated approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

* Age 50-74 years (inclusive)
* Confirmed body mass index (BMI) between ≥27.0 and \<45.0 based on weight and height measured by study staff at device distribution
* Confirmed weight ≤396 lbs
* Patient Health Questionnaire-9 (PHQ-9) scores between ≥10 and \<20, indicating moderate to moderately severe depressive symptoms
* Self-identified race and ethnicity other than non-Hispanic White
* Willing and able to accept randomization, and provide informed e-consent and HIPAA authorization

Exclusion Criteria

* Unable to speak, read, understand English sufficiently for informed consent
* No reliable Wi-Fi Internet access at home
* Pre-existing type 1 or type 2 diabetes, coronary heart disease, heart failure, stroke, cancer diagnosis (other than non-melanoma skin cancer) or treatment in the past 12 months, end-stage organ failure, residence in a long-term care facility, life expectancy \<24 months
* Self-report of weight change \>15 lbs. during prior 3 months
* Current active weight loss treatment, including research-based commercial weight loss programs (e.g., Weight Watchers, Jenny Craig, HMR, Omada, TOPS), other programs led by trained personnel (professional or lay) at the recruiting clinic or in the local community
* Taking prescription medications regularly that affect appetite/weight (e.g., anti-obesity medicines, oral corticosteroids, oral hypoglycemics, etc.) for chronic disease management
* Planned or prior bariatric surgery (Note: patients who are more than 2 years post bariatric surgery may otherwise be eligible)
* Screen positive for bulimia nervosa using PHQ- eating disorder module
* Unable to pass the Revised Physical Activity Readiness Questionnaire (PAR-Q) or obtain physician clearance to participate
* Active suicidal ideation (PHQ-9 item 9 score ≥1 or SCL-20 item 2 score ≥2) with active plan and/or intent
* Bipolar or psychotic disorder, or pharmacotherapy or psychotherapy (individual or professionally-led group therapy), or brain stimulation therapy for depression or any other psychiatric condition
* Cognitive impairment based on the Callahan 6-item screener
* Active alcohol or substance use disorder (including prescription drugs) based on the CAGE Questionnaire Adapted to Include Drugs (CAGE-AID)
* Current or planned pregnancy or lactating (\<6 months postpartum)
* Participation in other behavioral, medical or surgical treatment studies by self-report that conflict with the primary weight loss and depression outcomes of this study
* Family/household member of an already enrolled participant or of a study team member
* Investigator discretion for serious safety or protocol adherence reasons

Where it's running

  • Department of Medicine, Vitoux Program on Aging and Prevention
    Chicago, Illinois, United States
    Recruiting
  • Washington University School of Medicine in St Louis
    St Louis, Missouri, United States
    Not yet recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.